Research Roundup: Apr 29, 2026
- 2 hours ago
- 2 min read
Best of cannabinoid science this week...
For migraines, this data from the UK Medical Cannabis Registry found that the initiation of cannabis-based medicine led to improvements over the next 2 years
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine
For drug-resistant migraines, a case report of a 1:1 THC:CBD oil reducing headache days by half, lowering pain intensity, improving sleep quality & enhancing quality of life
Use of Therapeutic Cannabis Oil for Drug-Resistant Migraine: A Case Report
For menstrual migraines, a combination of PEA & phycocyanin (a pigment-protein complex from bacteria) reduced migraine severity, duration, painkiller usage & the associated symptoms including nausea, vomiting & photophobia
Effectiveness of an Oral Supplementation of Phycocyanin and Palmitoylethanolamide for a Short-Term Prophylaxis of Menstrual Migraine: A Retrospective Observational Study
For inflammatory bowel disease, a survey found that the predominant use of CBD was for anxiety, insomnia & pain
Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population
On cannabinoids for dermatology, this review covered the evidence for many diseases & the barriers to clinical use (great charts!)
Cannabinoids for Dermatological Applications: Mechanistic Insights, Clinical Evidence, and Emerging Nanotechnology-Enabled Delivery Strategies
For wound healing & bone regeneration, a review of the mechanisms used by CBD (nice charts)
Pharmacological Insights into Cannabidiol for Wound Healing and Bone Regeneration
For motor control disorders, a review on the location of cannabinoid receptors in key motor pathways & the growing importance of the CB1 & CB2 receptors (nice charts)
Cannabinoids in Motor Control: From Receptor Distribution to Motor Disorders
For the muscle-relaxing effects of cannabinoids, this review examined the potential benefits for inflammation, pain & arthritis
Cannabis sativa Linn.: A Medicinal Plant with Promising Muscle Relaxant-related Constituents
For diabetic heart disease, a review on the benefits of CBD for inflammation, oxidative stress & scarring
Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges
For epilepsy, MS & depression, a review on the benefits of CBD
Emerging Cannabidiol Research in Neurological Disorders: Insights into Epilepsy, Multiple Sclerosis, and Depression
In a mouse model of multiple sclerosis, CBDA improved neurological scores & increase the levels of TNFα (important for immunomodulation)
Anti-Neuroinflammatory Cannabinoid Acids as a New Therapeutic Approach for Multiple Sclerosis
In a mouse model of cystitis in the lower urinary tract, CBD promoted the restoration of damaged structures, improved the integrity of the blood-urine barrier & reduced inflammation
CBD Promotes Structural and Functional Epithelial Restoration and Alleviates Inflammation in a Mouse Model of Interstitial Cystitis
Comments